BRIEF-Ionis Pharmaceuticals Q1 Revenue USD 132 Million Vs. IBES Estimate USD 125.3 Million

Reuters
Yesterday
BRIEF-Ionis Pharmaceuticals Q1 Revenue USD 132 Million Vs. IBES Estimate USD 125.3 Million

Apr 30 (Reuters) - Ionis Pharmaceuticals Q1 adjusted operating expenses USD 249 million.

  • Q1 operating income USD -146 million
  • Q1 net income USD -147 million
  • Q1 operating expenses USD 278 million
  • Q1 adjusted operating income USD -117 million vs. IBES estimate USD -175.9 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10